Immunogenicity and safety of a live attenuated varicella vaccine in children aged 1 to 12 years: A double-blind, randomized, parallel-controlled phase III clinical trial in China

Immunogenicity and safety of a live attenuated varicella vaccine in children aged 1 to 12 years: A double-blind, randomized, parallel-controlled phase III clinical trial in China

Chickenpox outbreaks frequently occur in collective settings such as kindergartens and schools, posing a significant threat to children’s physical and mental health. This study aimed to evaluate the immunogenicity and safety of the freeze-dried live attenuated varicella vaccine (VarV) developed by B...

Full description

Saved in:
Bibliographic Details
Main Authors: Shiyuan Wang, Yang Zhang, Guifan Li, Jinhui Shi, Xianyun Chang, Hao Zhang, Fengcai Zhu, Jingxin Li, Kai Chu, Jinfang Sun
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Varicella vaccine
chickenpox
pediatric
phase III
immunogenicity
safety
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2452681
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items